You have 9 free searches left this month | for more free features.

PET imaging

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence

Not yet recruiting
  • 68Ga-FAPI
  • +3 more
  • 68Ga-FAPI
  • Shanghai, Shanghai, China
    Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
May 3, 2023

Hypercholesterolemia, Hypercholesterolemia, Familial Trial in Cambridge (PCSK9 inhibitor, 68Ga-DOTATATE PET-MRI)

Not yet recruiting
  • Hypercholesterolemia
  • +3 more
  • Cambridge, United Kingdom
    University of Cambridge
Jan 13, 2023

Cancer Trial in Stanford (68Ga-FAPI, Computed Tomography (CT) scan, Positron Emission Tomography (PET) scan)

Not yet recruiting
  • Cancer
  • Stanford, California
    Stanford University Hospitals and Clinics
Nov 9, 2022

Non-Hodgkin's Lymphoma, Myeloma, Active Solid Malignancy Trial in New York (PET Imaging using 124 IPUH71)

Active, not recruiting
  • Non-Hodgkin's Lymphoma
  • +2 more
  • PET Imaging using 124 IPUH71
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 10, 2023

Prostatic Cancer Trial in Wuxi (68Ga-labeled NY108)

Recruiting
  • Prostatic Cancer
  • 68Ga-labeled NY108
  • Wuxi, Jiangsu, China
    Affiliated Hospital of Jiangnan University
Nov 27, 2022

Renal Cell Carcinoma Trial in Wuxi (68Ga-NY104)

Recruiting
  • Renal Cell Carcinoma
  • Wuxi, Jiangsu, China
    Affiliated Hospital of Jiangnan University
Nov 27, 2022

Multiple Sclerosis Trial run by the NIMH (11C-MCI, 11C-PS13)

Recruiting
  • Multiple Sclerosis
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023

Intestinal Fibrosis in Crohn's Disease Based on 18F-FAPI PET

Recruiting
  • Crohn Disease
    • Chongqing, Chongqing, China
      Department of Nuclear Medicine, Daping Hospital of Army Medical
    Apr 20, 2023

    Prostate Cancer Trial in Bala-Cynwyd (rhPSMA-7.3 (18F))

    Not yet recruiting
    • Prostate Cancer
    • rhPSMA-7.3 (18F)
    • Bala-Cynwyd, Pennsylvania
      MidLantic Urology
    Mar 22, 2023

    Depression Trial run by the NIMH (11C-MCI, 11CPS13)

    Recruiting
    • Depression
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan Trial (18F-PMPBB3 (APN-1607) PET imaging)

    Recruiting
    • Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan
    • 18F-PMPBB3 (APN-1607) PET imaging
    • Taipei, Taiwan
      National Taiwan University Hospital
    Nov 24, 2022

    HER2-positive Breast Cancer Trial in Shanghai (68Ga/131I-SGMIB-5F7)

    Not yet recruiting
    • HER2-positive Breast Cancer
    • 68Ga/131I-SGMIB-5F7
    • Shanghai, China
      Huashan Hospital
    Aug 1, 2023

    Tumors Trial in Beijing ([68Ga]N188)

    Recruiting
    • Neoplasms
    • Beijing, Beijing, China
      Peking University First Hospital
    Jan 27, 2023

    Breast Cancer Stage II, Breast Cancer Stage III, Solid Tumor Trial in Wuxi ([18F]SF-DEVD-2, [18F]-FDG)

    Recruiting
    • Breast Cancer Stage II
    • +2 more
    • Wuxi, Jiangsu, China
      Affiliated Hospital of Jiangnan University
    Apr 22, 2023

    Lesion With Known or Suspected F-choline Uptake Trial in Montréal (F-choline intravenous injection)

    Recruiting
    • Lesion With Known or Suspected F-choline Uptake
    • F-choline intravenous injection
    • Montréal, Quebec, Canada
      Centre Hospitalier de l'université de Montréal
    Dec 6, 2022

    Prostate Cancer, Recurrent Prostate Cancer Trial in Tampa (F-DCFPyL Injection, PSMA PET)

    Recruiting
    • Prostate Cancer
    • Recurrent Prostate Cancer
    • F-DCFPyL Injection
    • PSMA PET
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 24, 2023

    PSMA-PET Imaging of Salivary Gland Tumours and Other Rare

    Recruiting
    • Salivary Gland Tumor
    • Rare Malignant Neoplasm
    • 68-Ga PSMA PET scan
    • Singapore, Singapore
      National Cancer Centre Singapore
    Oct 11, 2022

    Grade III or Grade IV Glioma Trial (PET imaging with 18F fluciclovine)

    Not yet recruiting
    • Grade III or Grade IV Glioma
    • PET imaging with 18F fluciclovine
    • (no location specified)
    Jul 27, 2022

    Thymoma Trial in Beijing (68Ga-Pentixafor)

    Recruiting
    • Thymoma
    • Beijing, Beijing, China
      Peking Union Medical College Hospitall, Chinese Academy of Medic
    Oct 11, 2023

    Sickle Cell Disease Trial (Positron Emission Tomography, Cu-64]-LLP2A)

    Recruiting
    • Sickle Cell Disease
    • Pittsburgh, Pennsylvania
      UPMC
    Dec 2, 2022

    SARS CoV-2 Post-Acute Sequelae Trial in Birmingham (DPA-714 PET/MRI)

    Not yet recruiting
    • SARS CoV-2 Post-Acute Sequelae
    • DPA-714 PET/MRI
    • Birmingham, Alabama
      UAB
    Dec 16, 2022

    Multiple Myeloma, Plasma Cell Myeloma Trial in San Francisco (drug, procedure, other)

    Not yet recruiting
    • Multiple Myeloma
    • Plasma Cell Myeloma
    • Zirconium Zr 89-DFO-YS5
    • +3 more
    • San Francisco, California
      University of California, San Francisco
    May 26, 2023

    Breast Carcinoma, Calcification Trial in Duarte (procedure, drug, other)

    Recruiting
    • Breast Carcinoma
    • Calcification
    • Computed Tomography
    • +3 more
    • Duarte, California
      City of Hope Medical Center
    Dec 13, 2022

    Metastatic Melanoma Trial in Marseille (PET with 18F-FDOPA)

    Completed
    • Metastatic Melanoma
    • PET with 18F-FDOPA
    • Marseille, France
      Assistance Publique Hopitaux de Marseille
    Nov 9, 2022

    18F-PFPN PET Imaging in Patients With Malignant Melanoma

    Recruiting
    • Melanoma
    • Wuhan, Hubei, China
      China, Hubei Province
    Dec 2, 2022